Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy

Details for Australian Patent Application No. 2004259204 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Kandimalla, Ekambar R.; Agrawal, Sudhir

Agent Freehills

Pub. Number AU-B-2004259204

PCT Pub. Number WO2005/009355

Priority 60/503,242 15.09.03 US; 60/487,529 15.07.03 US

Filing date 15 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 19 August 2010

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009355 Priority application(s): WO2005/009355

23 March 2006 Assignment before Grant

  Hybridon, Inc. The application has been assigned to Idera Pharmaceuticals, Inc.

19 August 2010 Application Accepted

  Published as AU-B-2004259204

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259205-Devices and methods for percutaneously treating aortic valve stenosis

2004259201-Method of minimizing herbicidal injury